Sanofi's Net Worth
Sanofi's net worth is estimated to be at least $13,421,682,596.80 as of 04/20/2024. CoreStreet's estimation of Sanofi's net worth is based on their sale of stock and current holding of stock.
Sanofi is Major Shareholder at Sanofi ADR. They have executed at least 57 trades of stock as per SEC Form 4 filings. Their most recent trade was for 66,667 units of SNY stock on 08/02/2021. Their biggest sale was on 05/29/2020 when they sold 20,421,899 units of Sanofi ADR stock for $10,412,105,205.15. They typically trade 7 times per year.
Total value of insider buys:
- $2,572,169,497.69
Total value of insider sells:
- $10,849,513,099.11
Most recent insider trade:
- Aug. 2, 2021
Sanofi's Insider Trading History
| Sanofi ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 2, 2021 | Major Shareholder | 66,667 | $15.00 | Buy | $1,000,005.00 |
July 28, 2020 | Major Shareholder | 81,250 | $16.00 | Buy | $1,300,000.00 |
June 9, 2020 | Major Shareholder | 120,234 | $597.48 | Sell | $71,837,410.32 |
May 29, 2020 | Major Shareholder | 20,421,899 | $509.85 | Sell | $10,412,105,205.15 |
Sept. 10, 2019 | Major Shareholder | 172,904 | $281.15 | Sell | $48,611,959.60 |
July 22, 2019 | Major Shareholder | 93,750 | $16.00 | Buy | $1,500,000.00 |
March 8, 2019 | Major Shareholder | 131,115 | $412.17 | Sell | $54,041,669.55 |
Sept. 6, 2018 | Major Shareholder | 104,552 | $406.68 | Sell | $42,519,207.36 |
June 8, 2018 | Major Shareholder | 121,601 | $309.31 | Sell | $37,612,405.31 |
Aug. 24, 2017 | Major Shareholder | 105,820 | $482.04 | Buy | $51,009,472.80 |
Aug. 23, 2017 | Major Shareholder | 60,595 | $478.98 | Buy | $29,023,793.10 |
July 9, 2014 | Major Shareholder | 195,000 | $308.27 | Buy | $60,112,650.00 |
July 8, 2014 | Major Shareholder | 153,000 | $311.67 | Buy | $47,685,510.00 |
| Regeneron Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 10, 2019 | Major Shareholder | 172,904 | $281.15 | Sell | $48,611,959.60 |
March 8, 2019 | Major Shareholder | 131,115 | $412.17 | Sell | $54,041,669.55 |
Sept. 6, 2018 | Major Shareholder | 104,552 | $406.68 | Sell | $42,519,207.36 |
June 8, 2018 | Major Shareholder | 121,601 | $309.31 | Sell | $37,612,405.31 |
Aug. 25, 2017 | Major Shareholder | 72,378 | $481.36 | Buy | $34,839,874.08 |
Aug. 24, 2017 | Major Shareholder | 166,415 | $480.93 | Buy | $80,033,965.95 |
June 2, 2017 | Major Shareholder | 136,050 | $478.17 | Buy | $65,055,028.50 |
Jan. 11, 2017 | Major Shareholder | 87,298 | $369.71 | Buy | $32,274,943.58 |
June 14, 2016 | Major Shareholder | 64,731 | $363.86 | Buy | $23,553,021.66 |
Feb. 17, 2016 | Major Shareholder | 161,157 | $392.46 | Buy | $63,247,676.22 |
Jan. 12, 2016 | Major Shareholder | 83,938 | $465.04 | Buy | $39,034,527.52 |
Oct. 6, 2015 | Major Shareholder | 80,538 | $459.71 | Buy | $37,024,123.98 |
Sept. 23, 2015 | Major Shareholder | 147,209 | $534.67 | Buy | $78,708,236.03 |
Dec. 24, 2014 | Major Shareholder | 201,459 | $393.21 | Buy | $79,215,693.39 |
Sept. 16, 2014 | Major Shareholder | 31,717 | $349.26 | Buy | $11,077,479.42 |
Sept. 15, 2014 | Major Shareholder | 140,632 | $345.15 | Buy | $48,539,134.80 |
July 15, 2014 | Major Shareholder | 129,100 | $314.92 | Buy | $40,656,172.00 |
July 14, 2014 | Major Shareholder | 300,000 | $316.80 | Buy | $95,040,000.00 |
July 10, 2014 | Major Shareholder | 175,000 | $311.08 | Buy | $54,439,000.00 |
July 9, 2014 | Major Shareholder | 348,000 | $309.76 | Buy | $107,796,480.00 |
July 7, 2014 | Major Shareholder | 356,700 | $312.37 | Buy | $111,422,379.00 |
July 2, 2014 | Major Shareholder | 212,400 | $307.25 | Buy | $65,259,900.00 |
July 1, 2014 | Major Shareholder | 212,400 | $300.20 | Buy | $63,762,480.00 |
June 30, 2014 | Major Shareholder | 262,400 | $281.17 | Buy | $73,779,008.00 |
May 19, 2014 | major shareholder | 190,751 | $300.04 | Buy | $57,232,930.04 |
March 28, 2014 | major shareholder | 306,945 | $306.73 | Buy | $94,149,239.85 |
March 27, 2014 | major shareholder | 306,945 | $311.01 | Buy | $95,462,964.45 |
March 24, 2014 | major shareholder | 306,945 | $307.91 | Buy | $94,511,434.95 |
March 21, 2014 | major shareholder | 305,115 | $321.22 | Buy | $98,009,040.30 |
March 20, 2014 | major shareholder | 67,703 | $328.33 | Buy | $22,228,925.99 |
March 17, 2014 | major shareholder | 115,711 | $328.46 | Buy | $38,006,435.06 |
March 12, 2014 | major shareholder | 220,995 | $334.69 | Buy | $73,964,816.55 |
March 11, 2014 | major shareholder | 380,532 | $330.41 | Buy | $125,731,578.12 |
March 7, 2014 | major shareholder | 150,277 | $328.72 | Buy | $49,399,055.44 |
March 3, 2014 | major shareholder | 251,594 | $338.12 | Buy | $85,068,963.28 |
Feb. 7, 2014 | major shareholder | 168,511 | $286.78 | Buy | $48,325,584.58 |
Feb. 5, 2014 | major shareholder | 397,264 | $284.12 | Buy | $112,870,647.68 |
Feb. 3, 2014 | major shareholder | 208,972 | $283.78 | Buy | $59,302,074.16 |
Jan. 28, 2014 | major shareholder | 157,920 | $275.90 | Buy | $43,570,128.00 |
| Alnylam Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 31, 2017 | Major Shareholder | 297,501 | $71.87 | Buy | $21,381,396.87 |
Feb. 1, 2016 | Major Shareholder | 205,030 | $69.75 | Buy | $14,300,842.50 |
Jan. 29, 2015 | Major Shareholder | 97,118 | $95.00 | Buy | $9,226,210.00 |
March 25, 2014 | major shareholder | 344,448 | $66.88 | Buy | $23,036,682.24 |
| Regulus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 4, 2014 | major shareholder | 1,303,780 | $7.67 | Buy | $9,999,992.60 |